Cryosa

Roseville, United States Founded: 2014 • Age: 12 yrs
A therapeutic medical device is provided for treating sleep disorders.

About Cryosa

Cryosa is a company based in Roseville (United States) founded in 2014.. Cryosa has raised $35.74 million across 3 funding rounds from investors including HOYA, Solas BioVentures and Santé. The company has 16 employees as of December 31, 2022. Cryosa offers products and services including OSA Treatment Device. Cryosa operates in a competitive market with competitors including Inspire Medical, Apnex Medical, ImThera Medical, LinguaFlex and Zelegent, among others.

  • Headquarter Roseville, United States
  • Employees 16 as on 31 Dec, 2022
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Cryosa, Inc.
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $35.74 M (USD)

    in 3 rounds

  • Latest Funding Round
    $5.99 M (USD), Series B

    Jun 30, 2025

  • Investors
    HOYA

    & 2 more

  • Employee Count
    16

    as on Dec 31, 2022

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Cryosa

Cryosa offers a comprehensive portfolio of products and services, including OSA Treatment Device. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Innovative non-invasive solution for treating obstructive sleep apnea.

People of Cryosa
Headcount 10-50
Employee Profiles 4
Board Members and Advisors 2
Employee Profiles
People
Beth Duff
Sr. Clinical Trial Manager
People
Daisy Cross, Ph.D.
Consultant: Biology/Toxicology/Biomedical Engineering

Unlock access to complete

Funding Insights of Cryosa

Cryosa has successfully raised a total of $35.74M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $5.99 million completed in June 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Series B — $6.0M
  • First Round

    (25 Jun 2020)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2025 Amount Series B - Cryosa Valuation

investors

Sep, 2021 Amount Series B - Cryosa Valuation Solas BioVentures
Jun, 2020 Amount Series A - Cryosa Valuation Sante , HOYA
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Cryosa

Cryosa has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include HOYA, Solas BioVentures and Santé. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Santé is engaged in healthcare and technology investment management.
Founded Year Domain Location
A wide range of medical devices is developed by HOYA.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Cryosa

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Cryosa

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Cryosa Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Cryosa

Cryosa operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inspire Medical, Apnex Medical, ImThera Medical, LinguaFlex and Zelegent, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Neurostimulation devices are developed to treat obstructive sleep apnea.
domain founded_year HQ Location
Develops an active implant for treating sleep apnoea through hypoglossal nerve stimulation.
domain founded_year HQ Location
Implantable neurostimulation devices for obstructive sleep apnea are developed.
domain founded_year HQ Location
Tongue retractor device for sleep apnea
domain founded_year HQ Location
Physician tools for treating sleep disorders are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Cryosa

Medical device startup Cryosa reels in $8.25m
Venturecapitaljournal5 years ago

Frequently Asked Questions about Cryosa

When was Cryosa founded?

Cryosa was founded in 2014 and raised its 1st funding round 6 years after it was founded.

Where is Cryosa located?

Cryosa is headquartered in Roseville, United States. It is registered at Roseville, California, United States.

Is Cryosa a funded company?

Cryosa is a funded company, having raised a total of $35.74M across 3 funding rounds to date. The company's 1st funding round was a Series A of $8.25M, raised on Jun 25, 2020.

How many employees does Cryosa have?

As of Dec 31, 2022, the latest employee count at Cryosa is 16.

What does Cryosa do?

Cryosa was founded in 2014 and is headquartered in Roseville, United States. Medical devices in the therapeutics sector are developed and offered by the company, focusing on sleep disorder management. A minimally invasive device is provided for the diagnosis and treatment of Obstructive Sleep Apnea (OSA). Operations center on healthcare innovation for respiratory-related conditions, with distribution targeted at clinical settings in the United States.

Who are the top competitors of Cryosa?

Cryosa's top competitors include Inspire Medical, ImThera Medical and Zelegent.

What products or services does Cryosa offer?

Cryosa offers OSA Treatment Device.

Who are Cryosa's investors?

Cryosa has 3 investors. Key investors include HOYA, Solas BioVentures, and Santé.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available